Atria Investments, Inc

Position in GRFS — Grifols SA

CIK 1535865 Charlotte, NC

Position in GRFS

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$717,388

+$186,793 QoQ

Shares Held

101,326

+53.2% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#48

of 164 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Atria Investments, Inc holds $241,408,936 across 16 Drug Manufacturers - General names. GRFS ranks #15 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	234,831	$59,640,029
2	LLY	ELI LILLY & Co	34,121	$40,925,754
3	ABBV	AbbVie Inc.	154,317	$38,832,329
4	MRK	Merck & Co., Inc.	190,293	$24,452,650
5	AMGN	Amgen Inc	43,724	$15,833,334
6	AZN	Astrazeneca PLC	69,989	$13,271,314
7	GILD	Gilead Sciences, Inc.	76,216	$9,629,129
8	NVS	Novartis AG	60,245	$9,441,596

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$717,388	101,326	+53.2%	Shares	Sole	2026-07-28
2026-03-31	$530,595	66,159	+27.4%	Shares	Sole	2026-05-05
2025-12-31	$485,489	51,924	-40.9%	Shares	Sole	2026-02-05
2025-09-30	$874,876	87,839	+77.3%	Shares	Sole	2025-11-06
2025-06-30	$447,950	49,552	-1.5%	Shares	Sole	2025-08-04
2025-03-31	$357,512	50,283	+49.0%	Shares	Sole	2025-05-06
2024-12-31	$251,159	33,758	-12.8%	Shares	Sole	2025-02-06
2024-09-30	$343,895	38,727	-62.8%	Shares	Sole	2024-11-01
2021-12-31	$1,167,538	103,966	+23.9%	Shares	Sole	2022-02-04
2021-09-30	$1,226,056	83,919	-14.3%	Shares	Sole	2021-11-16
2021-06-30	$1,697,975	97,866	+15.3%	Shares	Sole	2021-08-10
2021-03-31	$1,468,007	84,905	+17.1%	Shares	Sole	2021-05-11
2020-12-31	$1,337,231	72,518	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.